Format

Send to

Choose Destination
Genet Res Int. 2013;2013:784789. doi: 10.1155/2013/784789. Epub 2013 Dec 9.

Lack of TEK Gene Mutation in Patients with Cutaneomucosal Venous Malformations from the North-Western Region of Algeria.

Author information

1
Laboratory of Applied Molecular Biology and Immunology, University of Tlemcen, 13000 Tlemcen, Algeria.
2
Laboratory of Applied Molecular Biology and Immunology, University of Tlemcen, 13000 Tlemcen, Algeria ; Service de Stomatologie et de Chirurgie Buccale du Centre Hospitalier et Universitaire de Tlemcen, 13000 Tlemcen, Algeria.
3
Génétique Médicale, Laboratoire de Cytologie Clinique et Cytogénétique, CHU de Nîmes, Place du Professeur Robert Debré, 30029 Nimes Cedex 9, France.
4
Unité Médicale des Maladies Auto-Inflammatoires, Département de Génétique, CHRU, Montpellier, 34961 Montpellier Cedex 2, France ; Université Montpellier 1, 34961 Montpellier Cedex 2, France ; Génétique des Maladies Auto-Inflammatoires et des Ostéo-Arthropathies Chroniques, INSERM U844, 34091 Montpellier Cedex 5, France.
5
Laboratoire d'Immunogénétique Moléculaire, Institut de Génétique Humaine, CNRS UPR 1142, et Université Montpellier 2, 34095 Montpellier Cedex 5, France.
6
Unité Médicale des Maladies Auto-Inflammatoires, Département de Génétique, CHRU, Montpellier, 34961 Montpellier Cedex 2, France.

Abstract

BACKGROUND:

Venous malformations (VM) result from an error in vascular morphogenesis. The first gene suspected in their development is the TEK gene (tyrosine kinase, endothelial). Mutations of this gene have been identified in several Belgian families with a dominant form of the disease. Therefore, we investigated whether mutations in this TEK gene could explain the MV development in patients of families from Tlemcen region (north-western Algeria).

METHODS:

Genomic DNA was extracted from leucocytes of ten patients. The search for mutations in all the 23 exons and in the 5' and 3' intronic sequences flanking the TEK gene was performed using PCR amplification and direct sequencing of amplified genomic DNA. Additionally, a search for somatic mutations of the gene TEK was performed on a biopsy of the venous malformation from one of the ten eligible patients.

RESULTS:

The sequencing of the 23 exons of the TEK gene revealed neither germinal mutation in our ten patients nor somatic mutation in the tissue of the biopsy.

CONCLUSION:

The absence of mutation in the TEK gene in the population studied suggests that the TEK gene is not necessarily involved in the onset of VM; its association with these malformations may differ from one population to another.

Supplemental Content

Full text links

Icon for Hindawi Publishing Corporation Icon for PubMed Central
Loading ...
Support Center